Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
about
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyChromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasCancer therapy in the necroptosis eraCHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress responseDifferential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancerHSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.Necroptosis: an alternative cell death program defending against cancer.Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients.Necroptotic cell death in failing heart: relevance and proposed mechanisms.Cancer and necroptosis: friend or foe?Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.Relevance of necroptosis in cancer.Necroptosis and Cancer.Initiation and execution mechanisms of necroptosis: an overview.Necroptosis in cancer: An angel or a demon?Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.Phosphorylated MLKL causes plasma membrane ruptureLow CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.Necroptotic cell death in anti-cancer therapy.Cationic liposome co-encapsulation of SMAC mimetic and zVAD using a novel lipid bilayer fusion loaded with MLKL-pDNA for tumour inhibition in vivo.Regulation of alveolar macrophage death in acute lung inflammation.Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis.Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
P2860
Q26739959-2D85B9FC-55E6-42EC-8C62-20690E12059BQ26751724-21779A39-515B-4202-898E-F7FC41F59BB2Q26766339-4F0273DF-A4E9-456F-B1DA-312472272A3CQ33630872-412A6578-6951-415A-93DC-51D6529C1B9EQ34313054-707AE1E0-1B1A-4A17-B638-086D467EA2FBQ36347249-6ED4B3CE-E6DA-40E2-8771-00B375234CA4Q36464781-F38C063A-53B1-42E5-8B71-9E007D1BB805Q36751725-069F87E2-CB9C-4CB3-BE8B-A83CD7CF1DCEQ36880241-46902898-61FB-4BA1-9B07-0174A510626EQ37278775-677EFDCD-715F-4272-A027-56184CC49202Q38731479-B703FB03-E530-4C9D-A590-19681EFBFCD2Q38799139-270F36BA-E32B-49D5-AFE1-1705E6CAC8D0Q38880884-D43ADC4E-87A2-46AA-BF27-5A727082AAC7Q39030578-8C6CC8C1-E7A1-49DA-9A62-21EF9D372A8EQ39268644-F638967A-DE85-4DDC-A892-6D63C38C1BBAQ39302537-C0CF0430-25DA-490B-9B5A-61517886592AQ39398933-4F2A9CCA-CDFA-4E3D-B253-72125B8DDC96Q42012370-17850667-4946-4F05-9C6A-D2EBEB58A215Q42073367-4EC7A73A-2A70-4949-90F3-4A61D26FCB3BQ43989091-428ED46B-1D8C-4AD6-A735-141EFEEEAE9EQ47659073-D6FDC75F-C56F-4131-B359-B1E5FEE5DCD5Q50924028-4114214F-C030-4FE0-9165-A6CEE24702ECQ55355554-29870904-2E7D-4845-990A-43066032C676Q55669839-D6DB0D28-B945-41F7-8368-57AE2861CFB7Q58708239-04073D77-3BFB-4FB6-9D45-B224C02FE860
P2860
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@ast
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@en
type
label
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@ast
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@en
prefLabel
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@ast
Pronecrotic mixed lineage kina ...... ted pancreatic adenocarcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Pronecrotic mixed lineage kina ...... cted pancreatic adenocarcinoma
@en
P2093
Aleksandra V Petrova
Bassel F El-Rayes
Brooke G Pantazides
Burcu Saka
Charles A Staley
Claire W Hardy
David A Kooby
David S Yu
Jerome C Landry
Joseph W Shelton
P2860
P304
P356
10.1002/CNCR.28144
P407
P577
2013-05-29T00:00:00Z